Status:

NOT_YET_RECRUITING

Multiparameter Optimized tES for Memory in Aging

Lead Sponsor:

Medical University of South Carolina

Conditions:

Healthy Aging

Eligibility:

All Genders

50-85 years

Phase:

NA

Brief Summary

With an aging population worldwide, it is critical to develop effective interventions promoting healthy cognitive aging. Transcranial electrical stimulation (tES) is a promising but not fully realized...

Detailed Description

With an aging population worldwide, it is critical to develop effective interventions promoting healthy cognitive aging. A key component of healthy cognition is intact working memory, an executive neu...

Eligibility Criteria

Inclusion

  • 50 - 85 y.o.
  • Endorse good health with no history of mental or physical illness
  • Willingness to adhere to the study schedule and assessments
  • Able to read consent document and provide informed consent.
  • English is a first or primary fluent language.

Exclusion

  • Any current psychiatric diagnosis or current Clinical Global Impression ratings of psychiatric illness \> 1
  • Neurodevelopmental disorders, history of Central Nervous System (CNS) disease, concussion, overnight hospitalization, or other neurologic sequela, tumors, seizures, meningitis, encephalitis, or abnormal CT or MRI of the brain
  • Any psychotropic medication is taken within 5 half-lives of procedure time
  • Any head trauma resulting in loss of consciousness
  • Visual impairment (except the use of glasses)
  • Inability to complete cognitive testing
  • Active participation or plan for enrollment in another evidence-based clinical trial affecting the psychosocial function
  • Repeated abuse or dependence upon drugs (excluding nicotine and caffeine) or taking medications including stimulants, modafinil, thyroid medication, or steroids
  • Implanted devices/ferrous metal of any kind
  • History of seizure or epilepsy, currently taking medications that lower seizure thresholds
  • Claustrophobia or other conditions that would prevent the MRI assessment.
  • Pregnancy (or suspected/possible pregnancy or plan to become pregnant in the short term).
  • Urine Pregnancy Test: If the subject is a woman of childbearing potential and /or a man capable of fathering a child before, during, and/or after participation precautions should be taken. Examples of acceptable methods of birth control for participants involved in the study include birth control pills, patches, Intrauterine Devices (IUD), condoms, sponges, diaphragm with spermicide, or avoiding sexual activity that could cause the subject to become pregnant.
  • Inability to adhere to the treatment schedule.
  • Inability to fit the wearable device to the user's head.

Key Trial Info

Start Date :

December 31 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT06491264

Start Date

December 31 2025

End Date

December 31 2026

Last Update

June 12 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.